Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 4.67 AUD 1.74% Market Closed
Market Cap: 379.4m AUD
Have any thoughts about
Mayne Pharma Group Ltd?
Write Note

Income Statement

Earnings Waterfall
Mayne Pharma Group Ltd

Revenue
395.5m AUD
Cost of Revenue
-169.6m AUD
Gross Profit
225.8m AUD
Operating Expenses
-381.1m AUD
Operating Income
-155.3m AUD
Other Expenses
-18.9m AUD
Net Income
-174.2m AUD

Income Statement
Mayne Pharma Group Ltd

Rotate your device to view
Income Statement
Currency: AUD
Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
343
N/A
158
-54%
62
-61%
190
+208%
278
+46%
395
+42%
Gross Profit
Cost of Revenue
(191)
(82)
(37)
(100)
(89)
(170)
Gross Profit
151
N/A
75
-50%
25
-67%
90
+265%
189
+110%
226
+19%
Operating Income
Operating Expenses
(169)
(131)
(167)
(256)
(287)
(381)
Selling, General & Administrative
(120)
(133)
(152)
(190)
(190)
(186)
Research & Development
(17)
(12)
(13)
(16)
(18)
(20)
Depreciation & Amortization
(56)
(48)
(39)
(57)
(63)
(60)
Other Operating Expenses
25
62
36
7
(16)
(115)
Operating Income
(17)
N/A
(56)
-225%
(142)
-154%
(165)
-17%
(97)
+41%
(155)
-59%
Pre-Tax Income
Interest Income Expense
(4)
(9)
(23)
(19)
(17)
1
Non-Reccuring Items
(97)
(81)
(44)
(85)
(63)
(35)
Total Other Income
0
0
0
0
0
0
Pre-Tax Income
(119)
N/A
(146)
-23%
(208)
-43%
(270)
-30%
(178)
+34%
(190)
-7%
Net Income
Tax Provision
26
(75)
(59)
(48)
(81)
21
Income from Continuing Operations
(93)
(220)
(268)
(317)
(259)
(169)
Income to Minority Interest
0
11
10
0
(0)
0
Net Income (Common)
(78)
N/A
(281)
-263%
59
N/A
117
+98%
(243)
N/A
(174)
+28%
EPS (Diluted)
-0.95
N/A
-3.41
-259%
0.71
N/A
1.42
+100%
-3.02
N/A
-2.18
+28%

See Also

Discover More